12 results
6-K
EX-99.2
IFRX
InflaRx N.V.
1 Nov 23
Current report (foreign)
8:04am
and commercialize Gohibic (vilobelimab) at the current price or at all. Further, if Gohibic (vilobelimab) becomes subject to a product recall, including
6-K
EX-99.2
IFRX
InflaRx N.V.
10 Aug 23
Report of Foreign Private Issuer
8:00am
, if Gohibic (vilobelimab) becomes subject to a product recall, including as the result of manufacturing errors, design/labeling defects or other
6-K
geeaalbb
24 Feb 21
Current report (foreign)
4:16pm
20-F/A
x93811d
29 Mar 19
Annual report (foreign) (amended)
4:23pm
424B4
75o5cpn
7 May 18
Prospectus supplement with pricing info
4:47pm
F-1
kgm3 jra3
2 May 18
Registration statement (foreign)
7:10am
20-F
ve2r1e9drywxpvy
29 Mar 18
Annual report (foreign)
12:00am
- Prev
- 1
- Next